Authors

The sleep doctor who lives with a disorder he treats

Pediatric sleep specialist Luis Enrique Ortiz, M.D., opens up about living with Type 1 narcolepsy with cataplexy, the long road to diagnosis and how the condition has shaped both his career and personal life.

Protecting Vulnerable Lives: The Importance of Improving Vaccine Coverage in Patients with Cancer

Our 2026 conversation with Eric C. Hunter, MBA, president and CEO of CareOregon, part 1

During the first part of a wide-ranging interview with MHE, Hunter discussed behavioral health and financial pressures on the Medicaid managed care plna he runs in Oregon.

The future of pharmacy: What the MHE 2026 Pharmacy Survey signals for the year ahead

The 2026 MHE Pharmacy Survey asked questions about most-favored nation drug pricing, PBM reform and HHS Secretary Robert F. Kennedy Jr.'s vaccine policies. Respondents rated direct-to-consumer drug sales by drugmaker as the most important development in the pharmaceutical sector this year.

Pharmacy Benefits for Today’s Employer Challenges

Sponsored by RxBenefits.

Prior authorization isn’t shrinking. Its savings are

The real challenge for health plans isn’t simply deciding how to automate prior authorization but using this regulatory moment to build a far more durable cost-management strategy.

Bridging the Gap between Providers and Payors Ultimately Benefitting Patients

The bispecific era in multiple myeloma — Future directions: Written recap

C. Brooke Adams, Pharm.D., BCOP, of Orlando Health discusses bispecific antibody therapies for multiple myeloma.

Aflibercept 8 mg Shows Promise in Reducing Injection Burden | AAO 2025

New findings reveal aflibercept 8 mg enhances vision and extends injection intervals for nAMD and DME patients, reducing treatment burden significantly.

Cancer and the Microbiome: A Gut Check | ASCO 2025

Gut bacteria produce metabolites that influence drug metabolism and affect immune cell function, potentially enhancing or inhibiting treatment effectiveness.

The biosimilars market is projected to nearly double — here's where the growth is coming from

From $37 billion to nearly $71 billion in a decade: a look at the forces driving biosimilars' next growth phase.

The women’s health conversation still has a migraine-sized gap

Women are disproportionately affected by migraine, and people with migraine can lose the ability to consistently participate in work, school and daily life.

Smile Omni Executes at Scale to Turn Intelligence Into Impact

Smile Digital Health’s Intelligence Hub operationalizes computable clinical knowledge into measurable outcomes. Learn how payers and providers use unified data, digital HEDIS, and guideline-driven intelligence to close care gaps, reduce friction, and deliver real ROI.

Q&A: Mayo Clinic leaders share strategies for managing high-cost drugs without breaking the bank | Asembia AXS26 Summit

Mayo Clinic experts said managing high-cost drugs requires clear definitions, strong formulary review processes and closer collaboration among health systems, payers and manufacturers to balance access, cost and quality of care.

As Boundaries of Specialty Pharmacy Change, So Must Patient Support Services | Asembia AXS25

Specialty drugs are increasingly entering general medicine. Experts at Asembia’s AXS Summit say the trend will put a premium on leveraging artificial intelligence, technology and cross-functional expertise to create more personalized, efficient patient support services.

AI’s allure drives some users into the shadows

The use of unsanctioned or unapproved artificial intelligence by healthcare workers created a significant liability risk, experts say.

AI in Pharmacy: Transforming Workflows and Patient Care

Health Begins at Home: Why Housing Has Become a Strategic Priority for Managed Care

For decades, healthcare organizations have invested billions of dollars to improve clinical care. Yet one of the strongest predictors of health outcomes isn't found in hospitals or physicians' offices—it's whether someone has a stable place to live.

Early Trial of Libtayo Combination Demonstrates Activity in Melanoma

Fianlimab plus Libtayo demonstrated persistent and significant clinical activity in patients with advanced melanoma.

What the Trump Presidency Will Mean for U.S. Healthcare and Managed Care

This webinar on "What the Trump Presidency Will Mean for U.S. Healthcare and Managed Care" includes panelists Lindsay Greenleaf, J.D., MBA; Ryann Hill, M.P.H. and Patrick Cooney, discussing possible changes to healthcare policies and programs under the Trump administration, including the future of the Inflation Reduction and Affordable Care Acts, PBM reform and Medicare Advantage.

Patrick Gleason, Pharm.D., Prime Therapeutics

Gleason considered going into the family mortuary business. In his decades at Prime Therapeutics, he has become one of the most respected people in the pharmacy benefit management industry. Next year, as the president of the Academy of Managed Care Pharmacy, he wants to combat misinformation about vaccines.

What the Trump Presidency Will Mean for U.S. Healthcare and Managed Care

This webinar on "What the Trump Presidency Will Mean for U.S. Healthcare and Managed Care" includes panelists Lindsay Greenleaf, J.D., MBA; Ryann Hill, M.P.H. and Patrick Cooney, discussing possible changes to healthcare policies and programs under the Trump administration, including the future of the Inflation Reduction and Affordable Care Acts, PBM reform and Medicare Advantage.

How the Move to Digital Pharmacy Addresses Brick and Mortar Closures | Asembia’s AXS25 Summit

Digital pharmacy solutions can help brick and mortar locations become more efficient, according to Sarah Thomas, VP of sales and commercialization at HealthDyne and David Skomo, COO of HealthDyne.

Treatment Options for Heart Failure Expands With Finerenone | ACC 2025

Finerenone, a nonsteroidal mineralocorticoid receptor antagonist, has been studied extensively in patients with mildly reduced or preserved ejection fraction.

Healthcare Is Local: How Proximity Drives Transformation in Dialysis for Underserved Communities

Sponsored by DaVita.

Remote and in-clinic models target early type 1 diabetes screening | ADA 2026

A fully remote genetic screening program and a multicenter quality improvement initiative both advanced early detection of type 1 diabetes.

Future Modalities for Infertility

Lucy van de Wiel, PhD, discusses how emerging technologies such as in vitro gametogenesis and gene editing show promise for addressing complex infertility cases, potentially revolutionizing reproductive medicine by offering new solutions for patients with genetic disorders, same-sex couples, and those with uterine factor infertility.

PBMI Innovator, Joseph Savasta

Joseph Savasta, founder and CEO of pharmacy benefit manager HarmonyRx, discusses why the company keeps rejecting acquisition offers amid PBM consolidation.

Modernizing Pharmacy Benefit Administration: Addressing Legacy System Friction for Health Plans

Cloud-based pharmacy benefit administration (PBA) platforms are providing transparency for pharmacies and patients.